Business Practice

View More Business Development Legal Policy Practice Regulatory

Business Development Legal Policy Practice Regulatory

Product Approvals and Launches

Stakeholder Summit

All Videos Insights Interviews Peer Exchange Podcasts Stakeholder Summit

Gastroenterology

Bone Health Dermatology Diabetes Gastroenterology Hematology Immunology Neurology Oncology Ophthalmology Rare Disease Respiratory Rheumatology

Conference Coverage

Conference Listing

Biosimilar Resources

Interactive Tools

Polls and Quizzes

WHEN CHOICE ARRIVES: Competition & Consequences

Authors Biosimilar Resources Interactive Tools Partners Polls and Quizzes Sponsored WHEN CHOICE ARRIVES: Competition & Consequences

Subscribe BIOSIMILAR APPROVALS

About
Editorial
Contact
Advisory Board
Do Not Sell My Information
Terms & Conditions
Privacy Policy

© 2025 MJH Life Sciences and Center for Biosimilars®. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Advertisement

Business PracticeSee All >

Business
Development
Legal
Policy
Practice
Regulatory

About
Editorial
Contact
Advisory Board
Do Not Sell My Information
Terms & Conditions
Privacy Policy

© 2025 MJH Life Sciences^™ and Center for Biosimilars®. All rights reserved.

Clinician and Managed Care Insights on Biosimilars for Inflammatory Diseases

EP. 1: Knowledge Gaps With Biosimilars

June 17th 2017

EP. 2: Differences Between Biosimilars and Generic Drugs

June 17th 2017

EP. 3: Approval Process for Biosimilars

June 17th 2017

EP. 4: Naming of Biosimilars

June 17th 2017

EP. 5: Clinical Experience With Biosimilars

June 17th 2017

EP. 6: Use of Biosimilars in Inflammatory Diseases

June 17th 2017

EP. 7: Cost and Prescribing Considerations for Biosimilars

June 17th 2017

EP. 8: Variables Affecting Cost for Biosimilars

June 17th 2017

EP. 9: Formulary Considerations for Biosimilars

June 17th 2017

EP. 10: Challenges in Discussing Biosimilars With Patients

June 17th 2017

Advertisement

Advertisement